carbamates and glucagon-like peptide 1

carbamates has been researched along with glucagon-like peptide 1 in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (12.50)	18.2507
2000's	0 (0.00)	29.6817
2010's	6 (75.00)	24.3611
2020's	1 (12.50)	2.80

Authors

Authors	Studies
Feinglos, MN; Hughes, AT; Luna, B	1
Bain, SC; Bodvarsdottir, TB; Bracken, RM; Deacon, CF; Dunseath, G; Holst, JJ; Lowe, GD; Luzio, S; Prior, SL; Rumley, A; Stephens, JW; Wareham, K	1
Ables, GP; Birtles, S; Blaner, WS; Buckett, LK; Ginsberg, HN; Goldberg, IJ; Hernandez-Ono, A; Huang, LS; Turnbull, AV; Vogel, S; Yang, KJ; Yu, S; Yuen, JJ	1
Bailey, T	1
Meillet, L	1
Hidaka, S; Seino, S; Seki, C; Takahashi, H; Yokoi, N	1
Agampodi, S; Jayasumana, C; Rathish, D; Senavirathna, I; Siribaddana, S	1
Gnesin, F; Hemmingsen, B; Kähler, LKA; Madsbad, S; Thuesen, ACB	1

Reviews

3 review(s) available for carbamates and glucagon-like peptide 1

Article	Year
The use of insulin secretagogues in the treatment of type 2 diabetes. Primary care, 1999, Volume: 26, Issue:4 Topics: Acarbose; Carbamates; Chromans; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Metformin; Peptide Fragments; Piperidines; Protein Precursors; Risk Factors; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Troglitazone	1999
Options for combination therapy in type 2 diabetes: comparison of the ADA/EASD position statement and AACE/ACE algorithm. The American journal of medicine, 2013, Volume: 126, Issue:9 Suppl 1 Topics: Algorithms; Carbamates; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Exenatide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Incretins; Insulin; Liraglutide; Metformin; Peptides; Piperidines; Practice Guidelines as Topic; Receptors, Glucagon; Sulfonylurea Compounds; Thiazolidinediones; Venoms	2013
Metformin monotherapy for adults with type 2 diabetes mellitus. The Cochrane database of systematic reviews, 2020, Jun-05, Volume: 6 Topics: Adult; Carbamates; Cardiovascular Diseases; Cause of Death; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin; Metformin; Myocardial Infarction; Piperidines; Quality of Life; Randomized Controlled Trials as Topic; Stroke; Sulfonylurea Compounds	2020

Trials

1 trial(s) available for carbamates and glucagon-like peptide 1

Article	Year
Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus. Diabetes research and clinical practice, 2011, Volume: 94, Issue:2 Topics: Adult; Aged; Analysis of Variance; Biomarkers; Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; E-Selectin; F2-Isoprostanes; Female; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glyburide; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Incretins; Insulin; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Metformin; Middle Aged; Oxidative Stress; Piperidines; Postprandial Period; Time Factors; Treatment Outcome; Wales	2011

Article

Year

Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus.

Diabetes research and clinical practice, 2011, Volume: 94, Issue:2

Topics: Adult; Aged; Analysis of Variance; Biomarkers; Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; E-Selectin; F2-Isoprostanes; Female; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glyburide; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Incretins; Insulin; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Metformin; Middle Aged; Oxidative Stress; Piperidines; Postprandial Period; Time Factors; Treatment Outcome; Wales

2011

Other Studies

4 other study(ies) available for carbamates and glucagon-like peptide 1

Article	Year
Intestinal DGAT1 deficiency reduces postprandial triglyceride and retinyl ester excursions by inhibiting chylomicron secretion and delaying gastric emptying. Journal of lipid research, 2012, Volume: 53, Issue:11 Topics: Animals; Carbamates; Carrier Proteins; Chylomicrons; Diacylglycerol O-Acyltransferase; Gastric Emptying; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Indoles; Male; Mice; Mice, Mutant Strains; Peptide Fragments; Postprandial Period; Receptors, Glucagon; Retinoids; Triglycerides	2012
[New medications for patients with type 2 diabetes]. Soins; la revue de reference infirmiere, 2014, Issue:789 Topics: Carbamates; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Incretins; Piperidines	2014
Characteristics of repaglinide effects on insulin secretion. European journal of pharmacology, 2018, Jun-05, Volume: 828 Topics: Animals; Calcium; Carbamates; Drug Interactions; Exocytosis; Glucagon-Like Peptide 1; Guanine Nucleotide Exchange Factors; Insulin; Insulin Secretion; Insulin-Secreting Cells; Intracellular Space; Mice; Mice, Inbred C57BL; Piperidines	2018
A low GLP-1 response among patients treated for acute organophosphate and carbamate poisoning: a comparative cross-sectional study from an agrarian region of Sri Lanka. Environmental science and pollution research international, 2019, Volume: 26, Issue:3 Topics: Acetylcholinesterase; Acute Disease; Adult; Atropine; Carbamates; Chronic Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Erythrocytes; Female; Glucagon-Like Peptide 1; Humans; Incidence; Incretins; Insecticides; Male; Middle Aged; Occupational Exposure; Organophosphate Poisoning; Sri Lanka	2019